Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation…

Overview of attention for article published in Addiction Science & Clinical Practice, March 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 36 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 639 followers.

@DrPoorman @JoeWrightMD @leyde_sarah @DrSarahAxelrath @DrSarahWakeman @DrKimSue @NanouTheNomad NIDA’s CTN has a trial going on right now to study tapering strategies, including sublocade https://t.co/frg64KKHtL

Reply Repost Favourite

@JonGiftosMD @PaulNWilliamz NIDA CTN currently conducting a clinical trial evaluating injectable bup as a discontinuation/tapering strategy. Agree with @JonGiftosMD that there isn’t robust evidence in this area. See https://t.co/6BUWIApf6h

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.